Platelet‐like particles reduce coagulopathy‐related and neuroinflammatory pathologies post‐experimental traumatic brain injury
- 11 June 2021
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 109 (12) , 2268-2278
Abstract
Coagulopathy may occur following traumatic brain injury (TBI), thereby negatively affecting patient outcomes. Here, we investigate the use of platelet-like particles (PLPs), poly(N-isopropylacrylamide-co-acrylic-acid) microgels conjugated with a fibrin-specific antibody, to improve hemostasis post-TBI. The objective of this study was to diminish coagulopathy in a mouse TBI model (controlled cortical impact) via PLP treatment, and subsequently decrease blood–brain barrier (BBB) permeability and neuroinflammation. Following an acute intravenous injection of PLPs post-TBI, we analyzed BBB permeability, ex vivo coagulation parameters, and neuroinflammation at 24 hr and 7 days post-TBI. Both PLP-treatment and control particle-treatment had significantly decreased BBB permeability and improved clot structure 24 hr post-injury. Additionally, no significant change in tissue sparing was observed between 24 hr and 7 days for PLP-treated cohorts compared to that observed in untreated cohorts. Only PLP-treatment resulted in significant reduction of astrocyte expression at 7 days and percent difference from 24 hr to 7 days. Finally, PLP-treatment significantly reduced the percent difference from 24 hr to 7 days in microglia/macrophage density compared to the untreated control. These results suggest that PLP-treatment addressed acute hypocoagulation and decreased BBB permeability followed by decreased neuroinflammation and fold-change tissue loss by 7 days post-injury. These promising results indicate that PLPs could be a potential therapeutic modality for TBI.Keywords
Funding Information
- American Heart Association (18PRE33990338)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (DP2HD084067)
- National Heart, Lung, and Blood Institute (R01HL130918)
This publication has 58 references indexed in Scilit:
- A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusionJournal of Neuroinflammation, 2013
- Traumatic Brain Injury-Associated CoagulopathyJournal of Neurotrauma, 2012
- Blood–brain barrier breakdown as a therapeutic target in traumatic brain injuryNature Reviews Neurology, 2010
- Haemostatic drugs for traumatic brain injury2010
- Coagulopathy in Severe Traumatic Brain Injury: A Prospective StudyJournal of Trauma: Injury, Infection & Critical Care, 2009
- Electromagnetic Controlled Cortical Impact Device for Precise, Graded Experimental Traumatic Brain InjuryJournal of Neurotrauma, 2007
- Implications of Fibrinogenolysis in Patients with Closed Head InjuryJournal of Neurotrauma, 2003
- Implications of Excessive Fibrinolysis and α2-Plasmin Inhibitor Deficiency in Patients with Severe Head InjuryNeurosurgery, 2001
- Delayed Hemispheric Neuronal Loss in Severely Head-Injured PatientsJournal of Neurotrauma, 2001
- Disseminated intravascular coagulation associated with massive brain injuryJournal of Neurosurgery, 1973